From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

A GP Perspective of the Australasian COVID-19 Conference

Share the link to this page with others to keep them informed

Following the recent 2022 Australasian COVID-19 Conference which ASHM coordinated, we delivered a 90-minute webinar on Monday August 08 sharing key conference findings from a general practice perspective.

While the session was tailored to General Practitioners, all health professionals were welcome to attend, with a broad range of topics covered.

The webinar was presented by Dr Nicole Allard and A/Prof Edwina Wright, and we encourage you to watch the recording if you missed the live presentation. You can access the recording here.